Skip to main content

Table 1 Baseline characteristics in patients with and without the combined endpoint (n = 227)

From: The prognostic value of mechanical left ventricular dyssynchrony in patients with acute coronary syndrome

  All (n = 227) No death, MI or HF (n = 142) Death, MI or HF (n = 85)  
Variables n (%) n (%) n (%) P
Demographics:     
Age (median, 25th–75th perc.) 67 (59–77) 62 (56–74) 74 (63–80) <0.001
Men 172 (76) 111 (78) 61 (72) 0.276
Risk factors:     
Hypertension 121 (53) 63 (44) 58 (68) <0.001
Diabetes Mellitus 51 (22) 29 (20) 22 (26) 0.340
Current smoker (missing n = 6) 43 (19) 33 (23) 10 (13) 0.049
Previous cardiovascular disease:     
Myocardial infarction 56 (25) 31 (22) 25 (30) 0.200
Heart Failure 19 (8) 2 (1) 17 (20) <0.001
Revascularization, PCI 33 (15) 23 (16) 10 (12) 0.359
Revascularization, CABG 10 (4) 4 (3) 6 (7) 0.132
Stroke 17 (8) 10 (7) 7 (8) 0.741
Laboratory measurements     
NTproBNP 24 h (median, 25th–75th perc.) (n = 189)) 1220 (535–3465) 724 (303–1887) 2300 (1030–26040) <0.001
eGFR (median, 25th–75th perc.) (n = 220) 81 (58–110) 92 (72–116) 66 (40–96) <0.001
Troponin I (median, 25th–75th perc.) (n = 207) 3.5 (0.41–10.4) 2.4 (0.28–9.6) 4.4 (0.57–10.7) 0.118
Index Diagnosis     
Myocardial infarction 188 (83) 119 (84) 69 (81) 0.612
Measurements of LV function     
EF simpson (median, 25th–75th perc.) 49 (41–56) 45 (35–52) 52 (45–58) <0.001
WMSI (median, 25th–75th perc.) 1.06 (1.00–1.33) 1.14 (1.00–1.56) 1.00 (1.00–1.16) <0.001
Intervention during admission     
Coronary angiography 192 (85) 132 (93) 60 (70) <0.001
PCI 109 (48) 81 (57) 28 (33) <0.001
CABG 25 (11) 13 (9) 12 (14) 0.248
Treatment at discharge     
Betablocker 211 (93) 135 (95) 76 (89) 0.114
Statin 209 (92) 137 (96) 72 (85) 0.003
ASA 217 (96) 141 (99) 76 (89) 0.001
Clopidogrel 148 (65) 103 (73) 45 (53) 0.003
ACE inhibitor/A2 blocker 173 (76) 101 (71) 72 (85) 0.012